HLS Therapeutics Inc.
HLS
Rang în acțiuni
#21936
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Preț acțiune
$2.94
Ultima sincronizare: 2026-10-21
Capitalizare de piață
$90.88M
Schimbare (1 zi)
-0.48%
Schimbare (1 an)
-26.92%
Țară
CA
Tranzacționează HLS Therapeutics Inc. (HLS)
Categorie
Healthcare
Istoric al prețului acțiunii pentru HLS Therapeutics Inc. (HLS)
Cel mai mare preț de închidere: $2.76 pe 2026-10-01
Cel mai mic preț de închidere: $0.42 pe 2010-01-01
Cel mai mic preț de închidere: $0.42 pe 2010-01-01
Istoric al prețului acțiunii pentru HLS Therapeutics Inc. din 2010 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | -6.31% |
| 2025 | 36.44% |
| 2024 | -11.68% |
| 2023 | -61.22% |
| 2022 | -36.61% |
| 2021 | -14.29% |
| 2020 | -5.41% |
| 2019 | 23.57% |
| 2018 | 504.45% |
| 2017 | 5.61% |
| 2016 | -1.13% |
| 2015 | 1.31% |
| 2014 | -15.58% |
| 2013 | 6.18% |
| 2012 | 24.32% |
| 2011 | 122.54% |
| 2010 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.41 | -4.16% |
IN
|
